VBI Vaccines Inc/BC Quarterly Other Assets, Noncurrent in USD from Q4 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
VBI Vaccines Inc/BC quarterly Other Assets, Noncurrent history and growth rate from Q4 2015 to Q1 2024.
  • VBI Vaccines Inc/BC Other Assets, Noncurrent for the quarter ending March 31, 2024 was $1.21M, a 8.01% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.21M -$105K -8.01% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.18M -$177K -13.1% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 $1.09M -$255K -18.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.11M -$286K -20.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.31M -$135K -9.34% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.36M +$96K +7.63% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $1.35M +$255K +23.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.4M +$445K +46.8% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.45M +$664K +84.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.26M +$620K +97% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $1.09M +$472K +75.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $951K +$324K +51.7% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $782K +$184K +30.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $639K +$19K +3.07% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $622K -$2K -0.32% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $627K +$20K +3.3% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $598K -$283K -32.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $620K -$215K -25.7% Dec 31, 2019 10-K 2021-03-02
Q3 2019 $624K -$489K -43.9% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $607K -$499K -45.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $881K -$315K -26.3% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $835K +$160K +23.7% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $1.11M +$599K +117% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $1.11M +$586K +113% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $1.2M +$641K +115% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 $675K +$21K +3.21% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $514K Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $520K Jun 30, 2017 10-Q 2017-07-31
Q1 2017 $555K Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $654K +$363K +125% Dec 31, 2016 10-K 2018-02-26
Q4 2015 $291K Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.